Starpharma (ASX:SPL) Partners with Radiopharm Theranostics to Develop Radiotherapy Asset
Starpharma (ASX:SPL) announces a research and option agreement with Radiopharm Theranostics to develop a novel radiotherapy asset.
Category: ASX-SPL
Starpharma
SPL (ASX:SPL) Announces Preliminary Financial Report
SPL (ASX:SPL) reports a 41% decrease in revenue and a 22% increase in loss for the year ended 30 June 2025.
Starpharma (ASX:SPL) Releases FY25 Financial Results
Starpharma (ASX:SPL) reports a 183% revenue increase and reduced losses in its FY25 financial results.
Starpharma (ASX:SPL) Announces Q3 FY25 Activities Report
Starpharma (ASX:SPL) announces Q3 FY25 report with advancements in partnerships, product launches, and financial performance.